David Truong is an Assistant Professor in the Department of Biomedical Engineering at NYU Tandon School of Engineering, and in the Department of Pathology at NYU Grossman School of Medicine. He received a B.S. from University of California, San Diego, a Ph.D. from The University of Texas at Austin, and NIGMS F32-supported postdoctoral training with Dr. Jef D. Boeke at NYU Langone Health. Prior to starting his research group, he was a founding team member of Neochromosome Inc (later acquired by Opentrons Robotics) with support of an NIAID small business innovative research award. He has been honored with a Delil Nasser Award by the Genetics Society, a faculty innovator award by the Northeast Bioengineering conference, and a DP2 New Innovator award/grant from NIAID. The Truong lab combines site-specific 鈥渂igDNA鈥� genome rewriting in human iPSCs with cell state programming and synthetic genetic circuits to build off-the-shelf generic 鈥渟mart cells鈥� for therapeutics, diagnostics, and modeling. His group focuses primarily on the neuro-immune axis, with an emphasis on Alzheimer鈥檚 Disease and cancer.